According to SOPHiA GENETICS's latest financial reports the company has $0.12 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.12 B | -31% |
2022-12-31 | $0.17 B | -32.68% |
2021-12-31 | $0.26 B | 172.56% |
2020-12-31 | $97.34 M | 428.04% |
2019-12-31 | $18.43 M | -66.06% |
2018-12-31 | $54.32 M |